U.S. Senator Marco Rubio (R-Fla.) became the latest presidential candidate to speak out on prescription drug prices, saying that some pharmaceutical companies are engaging in “pure profiteering” and that high prices threaten to “bankrupt our system.” Read More
“It’s a new issue that’s emerged over the last few years but it’s a significant one, because it threatens to bankrupt our system,” Rubio said after being asked about drug prices by an audience member. “It’s a complex issue but it’s one we have to confront.” Read More
Republican presidential contender Marco Rubio blasted pharmaceutical company “profiteering” on high-cost prescription drugs during a campaign stop this week – a sign that drug prices are becoming a lightning rod for both parties in the election. Read More
Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major… Read More
Exorbitant price tags associated with breakthrough treatments illustrate the broader challenges ahead for the U.S. health care system if excessive drug pricing is not addressed head on. Read More
Express Scripts has reached deals to cover two costly new cholesterol drugs and expects to spend roughly $750 million on them next year. Read More
POLITICO Group targeting drug costs enters early primary states By Brett… Read More
Across the country, Americans are finding the prices of the prescription drugs… Read More
Drug makers do not really want to explain how medicines are priced and, as a result, they have adopted an air of secrecy in which one cowboy can create havoc for an entire industry. Read More
As the 2016 presidential race heats up, prominent candidates are beginning to unveil comprehensive plans to address soaring prescription drug costs and the harmful impact their price tags have on Americans. Read More
Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection. Read More
"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More